Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

NYU Langone Health

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01315873Phase 2PrincipalInvestigator

Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma

Multiple Myeloma
Terminated
NCT02075021Phase 1/2PrincipalInvestigator

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma
Terminated

All 2 trials loaded